Reaction

Acute Promyelocytic Leukaemia Differentiation Syndrome reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 208 reports · 3 co-occurring drugs

As of the last recalculation, Acute Promyelocytic Leukaemia Differentiation Syndrome appears in 208 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is TRETINOIN (PRR 1,537.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Tretinoin781,537.91,552.9
Micafungin Sodium560.460.5
Sevoflurane336.636.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.